Xolo offers three distinct volumetric 3D printing solutions: Xell, Xube², and Custom Xube. Their initial product was THE XUBE. They also focus on materials specifically engineered for MedTech, Bio, and Optical applications.
Technological Advantage
Tomographic light projection technology enables smooth surfaces without layer lines; dramatically faster production
Differentiation
Value Proposition
Revolutionary volumetric printing creates smooth, high-resolution parts 10-100x faster than layer-by-layer methods.
How They Differentiate
Volumetric approach eliminates layer lines and support structures while dramatically reducing print time
Market & Competition
Target Customers
Medical device companies, dental labs, research institutions, industrial manufacturers
Industry Verticals
Medical Devices, Dental, Research, Industrial Design
Competitors
3D Systems Corporation, ANYCUBIC, Formlabs
Growth & Milestones
Growth Metrics
$11.6M total funding raised; Launched Xube2 commercial product in September 2024; Swarovski partnership October 2024; Growing customer base in academic and industrial research
Major Milestones
2019: Founded in Berlin; 2021-05: Raised €2.5M seed round; 2023-02: Raised €8M Series A; 2024-09: Launched Xube2 volumetric 3D printer; 2024-10: Swarovski partnership for crystal 3D printing; 2024: Hired Stephan Kuehr as CCO
Xolo is a Berlin-based hardware company that commercialized the first volumetric 3D printer, a category that departs from conventional layer-by-layer methods. Its tomographic light projection technology cures an entire volume of photopolymer resin simultaneously, producing smooth, high-resolution parts 10 to 100 times faster than LPBF or SLA systems. This approach removes layer lines and support structures, addressing two persistent limitations of traditional additive manufacturing.
The company offers three volumetric printing solutions: Xell, Xube², and Custom Xube. The Xube², launched in September 2024, is its flagship commercial system. Xolo also develops materials engineered specifically for MedTech, Bio, and Optical applications, positioning its platform for use cases where surface finish, speed, and material purity are critical.
Target customers include medical device companies, dental labs, research institutions, and industrial manufacturers. Notable named customers include Swarovski, which partnered with Xolo in October 2024 for crystal 3D printing, and Rousselot. The company has raised approximately €10.5 million from investors including DeepTech & Climate Fonds, HZG Group, Onsight Ventures, SquareOne, and BMWK.
Xolo competes indirectly with established SLA and DLP vendors such as 3D Systems, Formlabs, and ANYCUBIC, but its volumetric process occupies a distinct niche. The key open question is whether the technology can scale beyond photopolymer resins into engineering-grade materials and larger build volumes, which would determine its relevance for production-grade medical and industrial applications.
Competitive Intelligence
Competitors, SWOT analysis, and investment insights